KRTAP5-1 Inhibitors
KRTAP5-1 inhibitors encompass a variety of chemical compounds that indirectly influence the functional activity of KRTAP5-1 by affecting the keratinization process and the cellular mechanisms that control hair shaft formation. Acitretin and alitretinoin are retinoids that target keratinocyte differentiation. The actions of these compounds can lead to altered differentiation and proliferation of keratinocytes, which in turn can result in reduced functional activity of KRTAP5-1 due to changes in the keratin structure and associated proteins. Methotrexate, an antimetabolite, and cyclosporine A, an immunosuppressant, both have the capability to inhibit the rapid growth and hyperproliferation of keratinocytes, thereby potentially decreasing the activity of KRTAP5-1 by affecting the turnover and formation of keratin.
In addition, compounds like bexarotene and tazarotene, which are classified as rexinoids and topical retinoids respectively, act by binding to specific receptors that influence keratinocyte behavior. Their interaction with retinoid X receptors and subsequent modulation of keratinocyte differentiation can result in the downregulation of KRTAP5-1 activity as these cells are integral to keratin and KRTAP5-1 expression.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Acitretin | 55079-83-9 | sc-210754 | 25 mg | $151.00 | 1 | |
A retinoid that normalizes keratinocyte differentiation. Acitretin can lead to a decrease in KRTAP5-1 activity by altering the differentiation process of cells that express keratin and associated proteins. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
An antimetabolite that can inhibit the rapid growth of keratinocytes. Methotrexate may indirectly decrease KRTAP5-1 activity by affecting the overall turnover and formation of keratin. | ||||||
Bexarotene | 153559-49-0 | sc-217753 sc-217753A | 10 mg 100 mg | $55.00 $250.00 | 6 | |
A rexinoid that binds to retinoid X receptors, affecting keratinocyte differentiation and proliferation, which could result in the downregulation of KRTAP5-1 activity. | ||||||
Tazarotene | 118292-40-3 | sc-220193 | 10 mg | $103.00 | ||
A topical retinoid that normalizes the differentiation of keratinocytes. Its influence on keratinocyte differentiation may extend to a decrease in KRTAP5-1 activity. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
An immunosuppressant that can reduce keratinocyte hyperproliferation. It may lead to decreased KRTAP5-1 activity by altering the cellular environment where keratin and KRTAP5-1 are involved. | ||||||
Apremilast | 608141-41-9 | sc-480062 | 5 mg | $444.00 | ||
A phosphodiesterase 4 inhibitor that can lead to changes in keratinocyte proliferation. Apremilast may influence KRTAP5-1 activity by altering signaling pathways that affect keratinocyte function. | ||||||
JAK Inhibitor I | 457081-03-7 | sc-204021 sc-204021A | 500 µg 1 mg | $156.00 $339.00 | 59 | |
As a class, these inhibitors can alter cytokine signaling, which can affect keratinocyte behavior and thus potentially decrease KRTAP5-1 activity. | ||||||
Salicylic acid | 69-72-7 | sc-203374 sc-203374A sc-203374B | 100 g 500 g 1 kg | $47.00 $94.00 $119.00 | 3 | |
A keratolytic that can disrupt keratin structures and keratinocyte adhesion, potentially leading to a decrease in KRTAP5-1 activity due to changes in the keratin environment. | ||||||